logo

Arcturus Therapeutics Ltd. (ARCT)



Trade ARCT now with
  Date
  Headline
6/5/2020 8:06:04 AM Arcturus Doses First Healthy Volunteer In Phase 1 Study With ARCT-810
4/27/2020 7:10:56 AM Arcturus Report Positive Preclinical Data From Study For COVID-19 Vaccine
4/9/2020 7:24:16 AM Arcturus To Initiate Human Clinical Trial This Summer For COVID-19 Vaccine, Also Known As LUNAR-COV19
3/27/2020 7:12:08 AM Arcturus Details About Strategy To Learn Safety Profile Of COVID-19 Vaccine
1/8/2020 7:15:09 AM Arcturus Therapeutics Appoints Steve Hughes As Chief Development Officer
9/23/2019 8:10:36 AM Arcturus Therapeutics Names Edward Holmes And Re-Appoints Andy Sassine To Board Of Directors
5/13/2019 7:15:04 AM Arcturus Therapeutics Q1 Net Loss $6.9 Mln Or $0.68/Shr Vs Loss Of $6.6 Mln Or $0.66/Shr Last Year
3/18/2019 7:06:55 AM Arcturus Therapeutics Q4 Net Loss $1.0 Mln Or $0.10 Per Share
1/3/2019 7:03:47 AM Arcturus Therapeutics Appoints Andrew Sassine As CFO
1/2/2019 7:05:05 AM Arcturus Therapeutics Plans To Develop ARCT-810 For Treatment Of Ornithine Transcarbamylase Deficiency
11/7/2018 7:24:31 AM Arcturus Therapeutics Q3 Net Loss $4.3 Mln Or $0.42/Shr Vs $3.2 Mln Or $1.51/Shr Last Year